Related Experiment Video
Updated: Apr 8, 2026
08:01
Generation and Expansion of Primary, Malignant Pleural Mesothelioma Tumor Lines
Published on: April 21, 2022
2.3K
Primary peritoneal serous psammocarcinoma: a case report
Răzvan Dan Togănel1, Ioan Şimon2, Adriana Zolog3
1Surgery Department CF Universitary Hospital, Iuliu Hatieganu University of Medicine and Pharmacy, Cluj-Napoca, Romania. toganel_r@yahoo.com.
Journal of Gastrointestinal and Liver Diseases : JGLD
|June 27, 2015
Summary
This case study highlights a rare psammocarcinoma (PCa) in a 54-year-old woman, successfully treated with surgery and chemotherapy. The patient shows no evidence of disease 12 months post-surgery, demonstrating a positive outcome for this rare ovarian or peritoneal tumor.
Area of Science:
- Gynecologic Oncology
- Surgical Pathology
- Abdominal Imaging
Background:
- Psammocarcinomas (PCas) are rare epithelial neoplasms.
- Typically originating in the ovaries or peritoneum.
- Characterized by psammomatous calcifications, invasiveness, and low-grade cytology.
Observation:
- A 54-year-old woman presented with an umbilical tumor and abdominal distension.
- Imaging revealed peritoneal nodules and large masses on the cecum and sigmoid colon.
- Surgical intervention included extensive resection of affected organs.
Findings:
- Pathology confirmed FIGO stage IIIC peritoneal psammocarcinoma.
- The patient received adjuvant chemotherapy with Taxol and Carboplatin.
- No evidence of disease was observed at 12-month follow-up.
Implications:
- Optimal debulking surgery is crucial for psammocarcinoma management.
- The efficacy of adjuvant chemotherapy requires further investigation.
- Rarity of PCas complicates the establishment of standardized treatment protocols.
